Biological Dynamics Announces Data Presentations at AACR Annual Meeting 2018

SAN DIEGO, Calif.–(BUSINESS WIRE)–#AACR18–Biological Dynamics, a molecular diagnostics company dedicated to
improving global health outcomes by empowering global communities with
low-cost, accessible cancer diagnostics, today announced that new data
on the company’s novel technology (ACE) will be presented at the
American Association for Cancer Research 2018 Annual Meeting, at
McCormick Place Convention Center on April 13 – 18 in Chicago.

Abstracts from two studies examining the application of the company’s
technology as an isolation platform for a novel class of biomarkers,
such as extracellular vesicles (EVs), and as a cell-free DNA
(cfDNA)-based diagnostic assay, will be presented:

Biological Dynamics announced on Friday, April 13, the addition of two
new members to its Board of Directors. Irwin Jacobs, founding Chairman
and CEO Emeritus of Qualcomm and Chairman Emeritus of the Salk Institute
for Biological Studies, and Martin J. Wygod, founder of Medco
Containment Services Inc. and former Chairman of WebMD Health Corp.,
have joined Biological Dynamics’ Board of Directors. (Read
more here.

About Biological Dynamics

Biological Dynamics is an innovative diagnostic company committed to
improving global cancer outcomes by empowering healthcare communities
with low-cost, accessible cancer diagnostics for labs and homes. The
company’s lab-on-a-chip platform offers a novel way to isolate cell-free
nanoparticles and macromolecules directly from whole blood, serum, or
plasma. The company is developing a suite of novel oncology tests for
early cancer detection, treatment response, and recurrence monitoring.
In addition to lab-focused products, the company is also developing a
smartphone-enabled portable version of the platform, extending molecular
testing into homes. For more information visit us at
and follow us at @BiodynSD on Twitter.


for Biological Dynamics
Krysta Pellegrino, 650-255-6142